Guangdong Biolight Meditech Co., Ltd. (300246.SZ)
CNY 6.63
(0.15%)
CNY 6.63
(0.15%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 381.5 Million CNY | 8.73% |
| 2022 | 357.28 Million CNY | 0.25% |
| 2021 | 356.39 Million CNY | -45.36% |
| 2020 | 652.24 Million CNY | 98.56% |
| 2019 | 328.49 Million CNY | 8.49% |
| 2018 | 302.77 Million CNY | 14.01% |
| 2017 | 265.57 Million CNY | 10.36% |
| 2016 | 240.63 Million CNY | 60.88% |
| 2015 | 149.57 Million CNY | 15.52% |
| 2014 | 129.48 Million CNY | 15.84% |
| 2013 | 111.78 Million CNY | 29.23% |
| 2012 | 86.49 Million CNY | 14.84% |
| 2011 | 75.31 Million CNY | 9.12% |
| 2010 | 69.02 Million CNY | 42.15% |
| 2009 | 48.55 Million CNY | 40.21% |
| 2008 | 34.62 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 71.15 Million CNY | -6.31% |
| 2024 Q2 | 75.44 Million CNY | 6.04% |
| 2024 Q3 | 71.02 Million CNY | -5.86% |
| 2023 Q4 | 75.94 Million CNY | -8.4% |
| 2023 Q1 | 132.16 Million CNY | 27.27% |
| 2023 Q2 | 97.47 Million CNY | -26.25% |
| 2023 FY | 388.48 Million CNY | 8.73% |
| 2023 Q3 | 82.9 Million CNY | -14.94% |
| 2022 FY | 357.28 Million CNY | 0.25% |
| 2022 Q3 | 85.28 Million CNY | 16.21% |
| 2022 Q1 | 94.76 Million CNY | 8.93% |
| 2022 Q2 | 73.38 Million CNY | -22.55% |
| 2022 Q4 | 103.84 Million CNY | 21.76% |
| 2021 Q2 | 97.44 Million CNY | 15.53% |
| 2021 Q1 | 84.34 Million CNY | 23.79% |
| 2021 Q3 | 87.6 Million CNY | -10.09% |
| 2021 Q4 | 86.99 Million CNY | -0.7% |
| 2021 FY | 356.39 Million CNY | -45.36% |
| 2020 FY | 652.24 Million CNY | 98.56% |
| 2020 Q4 | 68.13 Million CNY | -56.47% |
| 2020 Q3 | 156.51 Million CNY | -52.54% |
| 2020 Q2 | 329.76 Million CNY | 237.07% |
| 2020 Q1 | 97.83 Million CNY | 5.2% |
| 2019 Q4 | 92.99 Million CNY | 1.78% |
| 2019 FY | 328.49 Million CNY | 8.49% |
| 2019 Q1 | 69.9 Million CNY | -15.45% |
| 2019 Q2 | 74.23 Million CNY | 6.2% |
| 2019 Q3 | 91.36 Million CNY | 23.09% |
| 2018 Q3 | 74.32 Million CNY | -2.99% |
| 2018 Q2 | 76.61 Million CNY | 10.78% |
| 2018 Q4 | 82.67 Million CNY | 11.24% |
| 2018 FY | 302.77 Million CNY | 14.01% |
| 2018 Q1 | 69.15 Million CNY | 0.65% |
| 2017 Q4 | 68.71 Million CNY | -6.23% |
| 2017 FY | 265.57 Million CNY | 10.36% |
| 2017 Q1 | 60.07 Million CNY | -19.62% |
| 2017 Q3 | 73.27 Million CNY | 15.37% |
| 2017 Q2 | 63.51 Million CNY | 5.72% |
| 2016 Q2 | 53.6 Million CNY | 7.96% |
| 2016 FY | 240.63 Million CNY | 60.88% |
| 2016 Q1 | 49.64 Million CNY | 6.41% |
| 2016 Q4 | 74.73 Million CNY | 19.29% |
| 2016 Q3 | 62.65 Million CNY | 16.88% |
| 2015 Q2 | 25.96 Million CNY | -12.43% |
| 2015 Q4 | 46.66 Million CNY | -1.35% |
| 2015 Q3 | 47.3 Million CNY | 82.16% |
| 2015 FY | 149.57 Million CNY | 15.52% |
| 2015 Q1 | 29.65 Million CNY | -27.41% |
| 2014 Q2 | 29.4 Million CNY | -0.79% |
| 2014 Q3 | 29.6 Million CNY | 0.69% |
| 2014 Q4 | 40.84 Million CNY | 37.97% |
| 2014 FY | 129.48 Million CNY | 15.84% |
| 2014 Q1 | 29.63 Million CNY | -3.27% |
| 2013 Q1 | 22.05 Million CNY | -21.53% |
| 2013 Q3 | 28.24 Million CNY | -8.44% |
| 2013 Q4 | 30.63 Million CNY | 8.49% |
| 2013 FY | 111.78 Million CNY | 29.23% |
| 2013 Q2 | 30.84 Million CNY | 39.86% |
| 2012 Q1 | 15.73 Million CNY | -21.16% |
| 2012 Q4 | 28.1 Million CNY | 18.33% |
| 2012 Q3 | 23.75 Million CNY | 25.66% |
| 2012 FY | 86.49 Million CNY | 14.84% |
| 2012 Q2 | 18.9 Million CNY | 20.12% |
| 2011 Q1 | 13.34 Million CNY | -39.63% |
| 2011 FY | 75.31 Million CNY | 9.12% |
| 2011 Q2 | 25.82 Million CNY | 93.58% |
| 2011 Q4 | 19.95 Million CNY | 23.28% |
| 2011 Q3 | 16.18 Million CNY | -37.32% |
| 2010 Q3 | 17.27 Million CNY | 0.0% |
| 2010 Q4 | 22.1 Million CNY | 27.92% |
| 2010 FY | 69.02 Million CNY | 42.15% |
| 2009 FY | 48.55 Million CNY | 40.21% |
| 2008 FY | 34.62 Million CNY | 0.0% |